Novel genes with a role in deadly heart defects identified

Written By : Isra Zaman

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2023-07-19 03:30 GMT | Update On 2023-07-19 03:30 GMT

By identifying genes in patients and testing their effects in fruit flies, researchers from Sanford Burnham Prebys have found new genes that contribute to hypoplastic left heart syndrome (HLHS), a rare, life-threatening heart disease that occurs in infants. The findings, published in the journal eLife, bring scientists one step closer to unraveling the biology of this complex disease.

In babies with HLHS, the left side of the heart (left ventricle) is underdeveloped and unable to pump oxygenated blood to the rest of the body. Though rare, HLHS is extremely dangerous—it is nearly always fatal without multiple open-heart surgeries.

Genetics is thought to be a major driver of HLHS, but the specific genes involved have remained a mystery. To look for genes that contribute to HLHS, the researchers sequenced the genomes of 183 people with HLHS and their parents, including a family in which the parents were genetically related to each other. Focusing on this family helped the researchers narrow their search to a few key genes.

To test whether the genes they identified could be contributing to HLHS, the researchers performed genetic experiments on fruit fly hearts that are built with genes similar to those found in human hearts. They found that blocking the activity of these genes in flies interfered with their heart’s ability to contract, leading to significant heart defects.

Reference: Mitochondrial MICOS complex genes, implicated in hypoplastic left heart syndrome, maintain cardiac contractility and actomyosin integrity, eLife, DOI 10.7554/eLife.83385.

Full View

Article Source : eLife

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Novel genes with a role in deadly heart defects identified

Similar News

Can Taking 4,000 Steps Just Once a Week Lower the Risk of Death and Heart Disease? Study Provides Clarity

Can Fat You Can't See Put You at Risk for Stroke and Heart Attack?

AI Outperforms Traditional Tools in Predicting Heart Attack Risk: Study Finds

Non-Communicable Diseases Now Cause Two-Thirds of All Deaths: Lancet Study Finds

2 Common Drugs May Show Dual Benefit in Fatty Liver and Heart Disease: Study

Mini Workouts, Major Impact: Study Finds Exercise Snacks Improve Heart Fitness

Study Reveals Poor Early Heart Health Increases Lifetime CVD Risk 10-Fold

Cardiovascular Complications Now Affect 1 in 7 Pregnancies: AHA Study Suggests